Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

9th 3D Tissue Models Summit 2024

Evvnt Promotion / evvnt
Archivio
-
21.05.2024 - 23.05.2024  Omni Parker House, 60 School St, 02108 Boston, Massachusetts, USA
Time: 9:00 AM - 2:00 PM
 
Temi della conferenza
The FDA Modernization Act 2.0 has triggered a new mindset for pharma, with Roche launching the Institute of Human Biology to create better models, and MSD collaborating with Inventia to bioprint 3D in vitro models to screen for neurodegenerative therapeutic candidates.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/2224592-3?pid=4832

Speakers: Anastasia Korolj, PhD, Chemical and Biomedical Engineer, Harvard medical school/Massachusetts General Hospital, Beth Hoffman, Chief Executive Officer, Origami Therapeutics, Inc., and more
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/2224592-2?pid=4832
Mr. Alex Domingo
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
USD 2999.00 - USD 5097.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Center of ExcellenceÖsterreichische Akademie der ÄrzteEuropean Health Forum GasteinOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Alumni Club Medizinische Universität WienAGEM - Arbeitsgemeinschaft Ethnologie und MedizinÄrzte der WeltÖsterreichische Gesellschaft für Public Health